<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03497481</url>
  </required_header>
  <id_info>
    <org_study_id>2017-CHITS-02</org_study_id>
    <secondary_id>2017-A00183-47</secondary_id>
    <nct_id>NCT03497481</nct_id>
  </id_info>
  <brief_title>Neopterin Dosage in the Eye</brief_title>
  <acronym>CHA</acronym>
  <official_title>Appreciation of the Possibility of Dosing Neopterin in Eye Liquids. Pilot Study of Neopterin Dosage in Eye Liquids.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether neopterin can be dosed in the fluid of the
      eye's anterior chamber for patient with non-inflammatory and non-infectious ophthalmic
      pathology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be explained to subjects who are about to undergo ophthalmologic surgery. They
      will sign an informed consent and be included in the study. Urine sample will be collected
      specifically for the study. Eye's anterior chamber fluid will also be collected during the
      surgery as it is the usual practice (the sample is used for the neopterin dosage instead of
      being thrown away).

      These samples will be centrifuged, frozen in a -80° C freezer. At the end of the study, all
      the samples will be sent to the central Lab for the neopterin dosage analysis. Results will
      be communicated to the principal investigator afterward.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 30, 2018</start_date>
  <completion_date type="Anticipated">November 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection and dosage of neopterin in the eye</measure>
    <time_frame>3 month</time_frame>
    <description>HCL will detect and dose the neopterin in the eye's anterior chamber fluid</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neopterin concentration comparison between study values and reference value.</measure>
    <time_frame>3 month</time_frame>
    <description>The reference values are standards established by the Neurobiology Lab from Lyon CHU which is the central lab that will performed the neopterin dosages.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>False positives identification and elimination.</measure>
    <time_frame>3 month</time_frame>
    <description>False positives will be determined by calibration of creatinine dosage in eye and urine samples.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Neopterin Dosage</arm_group_label>
    <description>Eye's anterior chamber fluid and urines are sampled for posterior neopterin analysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Samples</intervention_name>
    <description>Eye's anterior chamber fluid and urines are sampled for posterior neopterin analysis</description>
    <arm_group_label>Neopterin Dosage</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      eye's anterior chamber fluid
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patient eligible for non infectious and non inflammatory eye surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years-old

          -  Non inflammatory or non infectious ophthalmic pathology requiring puncture of eye's
             anterior chamber fluid.

          -  Minimum of 200 microliter sample

          -  Immunocompetent subjects

          -  Signed and dated informed consent

          -  Samples management in accordance with the pre-analytical conditions specified in the
             protocol

        Non-inclusion criteria:

          -  Age &lt; 18 years-old

          -  Subjects treated with intraocular corticoids, antibiotics or anti-inflammatory,
             locally or in systemic injection, prior to inclusion.

        Exclusion Criteria:

          -  Subjects who exercised his right of withdrawal

          -  Study suspended on principal investigator, sponsor or health authorities' demand.

          -  Deceased subjects
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chaker Nefzaoui, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Intercommunal Toulon La Seyne sur Mer</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anélia Benarrosh, doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Centre Hospitalier Intercommunal Toulon La Seyne sur Mer</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anaïs Maugard</last_name>
    <phone>04.94.14.55.29</phone>
    <phone_ext>+33</phone_ext>
    <email>anais.maugardlandre@ch-toulon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mylène Vernisse</last_name>
    <phone>04.94.14.55.29</phone>
    <email>mylene.vernisse@ch-toulon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal Toulon La Seyne sur Mer</name>
      <address>
        <city>Toulon</city>
        <state>Var</state>
        <zip>83200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chaker Nefzaoui, Doctor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2018</study_first_submitted>
  <study_first_submitted_qc>April 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2018</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>eye's anterior chamber fluid</keyword>
  <keyword>cerebrospinal fluid</keyword>
  <keyword>inflammatory pathology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no plan</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

